Main Article Content
The present study reports the case of a 43-year-old female patient who presented with pulmonary benign metastasizing leiomyoma after a hysterectomy due to for leiomyoma of the uterus.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (firstname.lastname@example.org)
2. C. for D. and R. Health, Surgery Devices – Laparoscopic Power Morcellators (n.d.). https://www.fda.gov/medicaldevices/productsandmedicalprocedures/ surgeryandlifesupport/ucm584463.htm (Access: 25.02.2020).
3. Rivera JA, Christopoulos S, Small D et al. Hormonal manipulation of benign metastasizing leiomyomas: report of two cases and review of the literature. J Clin Endocrinol Metab. 2004; 89: 3183-8.
4. Wei WT, Chen PC. Benign metastasizing leiomyoma of the lung: a case report and literature review. Oncol Lett. 2015; 10(1): 307-12.
5. Sawai Y, Shimizu T, Yamanaka Y et al. Benign metastasizing leiomyoma and 18-FDG-PET/CT: A case report and literature review. Oncol Lett. 2017; 14(3): 3641-6.